ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

GRA, Regulatory Affairs Head – Canada at Eli Lilly and Company - ApplyBlast

GRA, Regulatory Affairs Head – Canada

Eli Lilly and Company

3 months ago

4.0 on Glassdoor

Toronto, Ontario, Canada

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The GRA, Regulatory Affairs Head – Canada leads the regulatory affairs group to ensure successful product registrations, line extensions, and new indications in alignment with the affiliate business plan while maintaining compliance with local regulations. The role involves developing regulatory strategies, overseeing submissions, managing audits, and leading a multicultural team in a hybrid Toronto office setting.

Responsibilities

Develop and implement regulatory plans and strategies
Lead Health Canada CTA and NDS submission processes
Manage regulatory compliance and audit activities
Provide leadership and mentorship to regulatory affairs team
Represent Lilly in external industry meetings and regulatory engagements

Skills

Qualifications

Bachelor's degree in physical or biological sciences

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.